BP

BridgeBio Pharma

BBIO
NASDAQHealth Care

Recent Patents

bbio
1 year ago

Filed a patent for "fused pyridazines for the treatment of cancer and other indications" on Tue, August 8, 2023

New US Patent
bbio
1 year ago

Filed a patent for "fused pyridines for the treatment of cancer and other indications" on Tue, August 8, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for inhibition of ras" on Tue, January 24, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis" on Wed, March 1, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "methods of treating skeletal dysplasias" on Mon, March 6, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "amido pyrido[3,4-b]indole-1,4-dione compounds for treatment of porphyrias" on Wed, April 26, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "methods of treating skeletal dysplasias" on Fri, June 16, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis" on Mon, July 31, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "assays for alpha-dystroglycan glycosylation and methods for using same" on Tue, March 14, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "gene therapy for galactosemia" on Fri, December 29, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for use in the treatment of cancer and other indications" on Mon, October 17, 2022

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for inhibition of ras" on Tue, December 6, 2022

New US Patent
bbio
over 1 year ago

Filed a patent for "collagen 7 compositions and methods of using the same" on Thu, December 28, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "benzoxazinone compounds as klk5/7 dual inhibitors" on Thu, February 29, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for inhibition of ras" on Tue, April 18, 2023

New US Patent
bbio
over 1 year ago

Filed a patent for "methods of preparing gene therapies" on Thu, January 4, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "formulations of triphenyl calcilytic compounds" on Thu, March 7, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for inhibiting kras" on Thu, July 25, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "gene therapies for 21-hydroxylase deficiency" on Thu, June 13, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "gene therapy for tuberous sclerosis" on Thu, August 8, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "processes for preparing ag-10, its intermediates, and salts thereof" on Thu, July 18, 2024

New US Patent
bbio
over 1 year ago

Filed a patent for "compositions and methods for inhibition of ras" on Thu, September 12, 2024

New US Patent
bbio
2 years ago

Filed a patent for "compositions and methods for inhibition of ras" on Fri, April 8, 2022

New US Patent
bbio
2 years ago

Filed a patent for "treatment methods with substituted pyrimidin-4(3h)-ones" on Wed, April 13, 2022

New US Patent
bbio
2 years ago

Filed a patent for "gene therapy for galactosemia" on Tue, May 17, 2022

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...